CIK 0001053691 · Non-accelerated filer<br>Smaller reporting company
CervoMed Inc.
Sign in to watch- Ticker
- CRVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300645032
- Phone
- (617) 744-4400
- Business address
- 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
- Former names
- Diffusion Pharmaceuticals Inc., RestorGenex Corp, Stratus Media Group, Inc, FERIS INTERNATIONAL, INC., TITAN MOTORCYCLE CO OF AMERICA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-14 | ZAVRL FRANK Director | Grant or award · Stock Option (Right to Buy) | +5,750 | 5,750 | ||
| 2024-02-26 | BOGER JOSHUA S Director | Option exercise | +495,995 | 840,487 | ||
| 2024-02-26 | BOGER JOSHUA S Director | Sale | −36 | 840,451 | ||
| 2024-02-26 | BOGER JOSHUA S Director | Option exercise · Pre-Funded Common Stock Purchase Warrant | −495,995 | 0 | ||
| 2024-02-12 | BOGER JOSHUA S Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-01-26 | ALAM JOHN J CEO & President | Grant or award · Stock Option (Right to Buy) | +35,500 | 35,500 | ||
| 2024-01-26 | Blackburn Kelly SVP, Clinical Development | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2024-01-26 | TANNER JOHN WILLIAM Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2024-01-26 | ELDER WILLIAM ROBERT GC & Secretary | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2024-01-26 | Gregoire Sylvie Director | Grant or award · Stock Option (Right to Buy) | +35,500 | 35,500 | ||
| 2024-01-26 | Cobuzzi Robert Joseph Jr. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +55,721 | 55,721 | ||
| 2023-11-20 | TANNER JOHN WILLIAM Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2023-11-09 | Gregoire Sylvie Director | Gift | −10,000 | 732,039 | ||
| 2023-11-09 | ALAM JOHN J CEO & President | Gift | −12,500 | 729,539 | ||
| 2023-09-15 | Cobuzzi Robert Joseph Jr. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2023-09-15 | TANNER JOHN WILLIAM Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2023-09-15 | ALAM JOHN J CEO & President | Grant or award · Stock Option (Right to Buy) | +35,500 | 35,500 | ||
| 2023-09-15 | ALAM JOHN J CEO & President | Grant or award · Stock Option (Right to Buy) | +6,450 | 6,450 | ||
| 2023-09-15 | ZAVRL FRANK Director | Grant or award · Stock Option (Right to Buy) | +6,450 | 6,450 | ||
| 2023-09-15 | Sabbagh Marwan Director | Grant or award · Stock Option (Right to Buy) | +6,450 | 6,450 |
Page 4 of 17 · 321 trades